Hepatic Lipidosis
Hepatic lipidosis
Also known as: Fatty liver disease, Avian hepatic lipidosis, Hepatic steatosis
Hepatic lipidosis
Also known as: Fatty liver disease, Avian hepatic lipidosis, Hepatic steatosis
In short
Feline hepatic lipidosis, commonly known as fatty liver disease, is a serious, life-threatening metabolic condition where fat builds up rapidly in a cat's liver cells. Often triggered by a period of decreased appetite, this condition requires prompt veterinary intervention. Fortunately, with early diagnosis and aggressive, long-term nutritional support, the disease is highly reversible, and most cats can make a full recovery.

TL;DR. Feline hepatic lipidosis (fatty liver disease) is a common, life-threatening condition where fat accumulates in liver cells after a period of not eating, but it is highly reversible with early, intensive nutritional therapy.

Hepatic lipidosis is a severe metabolic condition that often presents with lethargy and yellowing of the skin.
Feline hepatic lipidosis, often referred to as fatty liver disease, is one of the most common and severe liver diseases diagnosed in domestic cats. It is a metabolic disorder characterized by the massive, rapid accumulation of fat (specifically triglycerides) inside the cells of the liver (hepatocytes). As these cells swell with fat, they become physically compressed and lose their ability to function. This leads to acute liver failure, a life-threatening medical emergency.
To understand why this happens, it is helpful to look at feline physiology. Cats are obligate carnivores, meaning their bodies are highly adapted to a diet rich in protein and fat. When a cat stops eating—whether due to stress, a change in diet, or an underlying illness—their body enters a state of starvation. In response, the body begins rapidly mobilizing fat stores from around the body and sending them to the liver to be processed into energy.
Unfortunately, the feline liver is not equipped to handle this sudden, massive influx of fat, especially when deprived of the essential proteins needed to process it. Instead of being converted into usable energy, the fat accumulates within the liver cells. This causes severe swelling, blocks the microscopic bile ducts (a state called cholestasis), and rapidly impairs the liver's ability to filter toxins, produce vital proteins, and assist in digestion.
Hepatic lipidosis is classified into two main categories: primary (idiopathic) and secondary.
"Secondary lipidosis may occur in association with any disease causing anorexia, but has been most commonly recognized in cats with pancreatitis, diabetes mellitus (DM), other hepatic disorders, IBD, and neoplasia."
Obesity is the single most significant risk factor for hepatic lipidosis. Overweight cats have much larger stores of peripheral fat ready to be mobilized if they stop eating. When an obese cat experiences even a brief period of anorexia (often as short as 2 to 7 days), the risk of rapid fat mobilization and subsequent lipidosis is extremely high.
In terms of demographics, most affected cats are middle-aged, though the disease can occur in cats of any age, sex, or breed. There is no reported breed predilection for feline hepatic lipidosis.
The clinical signs of hepatic lipidosis can develop rapidly, often within days of a cat stopping or significantly reducing its food intake. Because the liver plays a central role in many bodily systems, the symptoms are widespread and affect multiple organs.

Icterus, or yellowing of the skin and tissues, is a cardinal sign of liver dysfunction in cats.
Diagnosing hepatic lipidosis requires a combination of physical examinations, blood tests, imaging, and cellular analysis. Because the symptoms of liver disease can mimic other common feline conditions like pancreatitis or inflammatory bowel disease (IBD), a thorough diagnostic workup is essential.
Your vet will begin by gathering a detailed history of your cat's appetite and behavior. They will perform a physical exam to check for muscle wasting, feel for an enlarged liver, and look for signs of icterus (yellowing) in the eyes, ears, and gums.
Blood work is crucial for assessing liver function. In cats with hepatic lipidosis, the results typically show marked abnormalities reflecting bile flow obstruction (cholestasis) and liver cell damage. As a leading veterinary reference states:
"Hyperbilirubinemia is present in more than 95% of cases, and levels of the hepatocellular enzymes alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are also markedly elevated in most cats."
Additionally, the enzyme alkaline phosphatase (ALP) is typically highly elevated, while another enzyme, gamma-glutamyltransferase (GGT), may remain normal or only mildly elevated. This specific pattern (high ALP with normal or low GGT) is highly suggestive of hepatic lipidosis in cats.
"Characteristically, the lipidotic liver appears hyperechoic, although this is not a specific finding and can also be seen in cats with other generalized parenchymal diseases, such as lymphoma or hepatic amyloidosis."

An ultrasound of a lipidotic liver typically reveals a bright, hyperechoic appearance due to fat accumulation.
"The only truly definitive and reliable method of diagnosing and identifying concurrent and causative conditions is histopathology of a wedge biopsy of liver obtained at laparotomy or laparoscopy or (less reliably) a Tru-Cut..."
Because taking a biopsy requires anesthesia and carries a risk of bleeding (especially in cats with compromised liver function), your vet will carefully weigh the benefits against the risks before proceeding with this step.
The treatment of hepatic lipidosis is intensive and focuses on reversing the metabolic starvation state, supporting liver function, and managing any underlying trigger diseases.
The absolute key to treating hepatic lipidosis is feeding. Because these cats are severely nauseous and completely refuse food, voluntary eating is rare. Forcing food by syringe is highly discouraged, as it causes severe stress, carries a high risk of accidental inhalation of food (aspiration pneumonia), and can cause the cat to develop a permanent aversion to food.
Instead, your vet will place a temporary feeding tube. The most common type is an esophagostomy tube (E-tube), which is placed surgically into the side of the neck while the cat is under brief anesthesia. This tube allows you to easily administer liquid veterinary diets, water, and medications directly into the stomach at home. Feeding must be introduced gradually to avoid "refeeding syndrome," a dangerous metabolic complication caused by introducing nutrients too quickly to a starving body. This nutritional therapy typically must be continued for 4 to 8 weeks until the cat begins eating on its own again.
Most cats with hepatic lipidosis are severely dehydrated and have critical electrolyte imbalances, particularly low potassium and phosphorus. Your vet will administer intravenous (IV) fluids in the hospital to restore hydration and carefully supplement electrolytes to prevent muscle weakness and red blood cell damage.
If your cat is experiencing pain—particularly if the lipidosis was triggered by a painful condition like pancreatitis—effective pain management is vital. Your vet may prescribe Buprenorphine, an opiate partial agonist, which is highly effective and safe for managing moderate to severe pain in cats.
Historically, hepatic lipidosis was associated with a very high mortality rate. However, with modern veterinary medicine and the early, aggressive use of feeding tubes, the prognosis has improved dramatically.
If the disease is diagnosed early and the fat can be successfully mobilized through consistent, intensive nutritional support, the condition is highly reversible. The vast majority of cats (often 80% to 90% with appropriate tube feeding) make a full recovery.
Furthermore, unlike dogs, cats rarely progress to permanent liver scarring or cirrhosis. As a leading reference notes:
"Cats typically have hepatobiliary disease or acute hepatic lipidosis, but chronic parenchymal disease is uncommon in this species; in addition, feline liver disease rarely progresses to cirrhosis, as is sometimes the case in dogs."
Once a cat recovers from hepatic lipidosis, they typically go on to live a normal, healthy life, provided any underlying secondary diseases (like diabetes or IBD) are managed long-term.
Preventing hepatic lipidosis centers on maintaining a healthy weight and ensuring your cat never experiences prolonged periods of starvation.
You should contact your veterinarian immediately if your cat has been eating significantly less or refusing food entirely for more than 24 to 48 hours.
Seek emergency veterinary care immediately if you notice any of the following red-flag symptoms:
Treatment must be prescribed by a licensed veterinarian based on your pet. Specific drug doses are intentionally not shown here.
Feline hepatic lipidosis, commonly known as fatty liver disease, is a serious, life-threatening metabolic condition where fat builds up rapidly in a cat's liver cells. Often triggered by a period of decreased appetite, this condition requires prompt veterinary intervention. Fortunately, with early diagnosis and aggressive, long-term nutritional support, the disease is highly reversible, and most cats can make a full recovery.
Hepatomegaly、Icterus、Biliverdinuria、Dehydration、Dyspnea、Lethargy、Muscle mass loss、Obesity
Histopathology of a liver wedge biopsy、Liver biopsy、Abdominal radiography、Abdominal ultrasonography、Coelomic Radiography、Fine-needle aspiration (FNA) cytology of the liver
Treatment must be prescribed by a licensed veterinarian based on your pet. Specific drug doses are intentionally not shown here.
This article is for general education and is not a substitute for professional veterinary advice. If your pet is unwell, please consult a veterinarian.
Peqaboo’s AI helps you track symptoms, understand lab reports, and know when to see a vet.
Get the Peqaboo app